Literature DB >> 24370135

Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI.

Andrew B Rosenkrantz1, Samir S Taneja.   

Abstract

OBJECTIVE: In this article, we describe 10 diagnostic challenges that may confound the interpretation of multiparametric prostate MRI for tumor, grouped into three categories on the basis of our experience: normal anatomic structures that may be misinterpreted as suspicious lesions if their normal appearance is not recognized, benign processes that may mimic tumor, and technical issues relating to acquisition and interpretation of diffusion-weighted imaging that may decrease sensitivity for tumor. Strategies for addressing these challenges are suggested.
CONCLUSION: It is important that the radiologist involved in the interpretation of prostate MRI be aware of these pitfalls that will be encountered during routine clinical practice. This awareness can contribute to improved diagnostic performance in MRI interpretation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24370135     DOI: 10.2214/AJR.13.10699

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  40 in total

1.  Possible clinical implications of peripheral zone changes depending on prostate size.

Authors:  Joshua M Frost; Lisa A Smith; Pranav Sharma; Werner T de Riese
Journal:  Int Urol Nephrol       Date:  2019-07-18       Impact factor: 2.370

2.  Assessment of prostate imaging reporting and data system version 2.1 false-positive category 4 and 5 lesions in clinically significant prostate cancer.

Authors:  Xiangyu Wang; Weizong Liu; Yi Lei; Guangyao Wu; Fan Lin
Journal:  Abdom Radiol (NY)       Date:  2021-03-12

3.  Diagnosis of typical and atypical transition zone prostate cancer and its mimics at multiparametric prostate MRI.

Authors:  Jinxing Yu; Ann S Fulcher; Sarah G Winks; Mary A Turner; Ryan D Clayton; Michael Brooks; Sean Li
Journal:  Br J Radiol       Date:  2017-03-29       Impact factor: 3.039

4.  Diagnosis of transition zone prostate cancer using T2-weighted (T2W) MRI: comparison of subjective features and quantitative shape analysis.

Authors:  Satheesh Krishna; Nicola Schieda; Matthew Df McInnes; Trevor A Flood; Rebecca E Thornhill
Journal:  Eur Radiol       Date:  2018-08-13       Impact factor: 5.315

Review 5.  Magnetic Resonance Imaging of the Prostate, Including Pre- and Postinterventions.

Authors:  Pritesh Patel; Aytekin Oto
Journal:  Semin Intervent Radiol       Date:  2016-09       Impact factor: 1.513

Review 6.  Biparametric MRI of the prostate.

Authors:  Michele Scialpi; Alfredo D'Andrea; Eugenio Martorana; Corrado Maria Malaspina; Maria Cristina Aisa; Maria Napoletano; Emanuele Orlandi; Valeria Rondoni; Pietro Scialpi; Diamante Pacchiarini; Diego Palladino; Michele Dragone; Giancarlo Di Renzo; Annalisa Simeone; Giampaolo Bianchi; Luca Brunese
Journal:  Turk J Urol       Date:  2017-12-01

Review 7.  Implementation of Multi-parametric Prostate MRI in Clinical Practice.

Authors:  Andrea S Kierans; Samir S Taneja; Andrew B Rosenkrantz
Journal:  Curr Urol Rep       Date:  2015-08       Impact factor: 3.092

8.  Diagnosis of Prostate Cancer with Noninvasive Estimation of Prostate Tissue Composition by Using Hybrid Multidimensional MR Imaging: A Feasibility Study.

Authors:  Aritrick Chatterjee; Roger M Bourne; Shiyang Wang; Ajit Devaraj; Alexander J Gallan; Tatjana Antic; Gregory S Karczmar; Aytekin Oto
Journal:  Radiology       Date:  2018-02-02       Impact factor: 11.105

Review 9.  Current Status of Hybrid PET/MRI in Oncologic Imaging.

Authors:  Andrew B Rosenkrantz; Kent Friedman; Hersh Chandarana; Amy Melsaether; Linda Moy; Yu-Shin Ding; Komal Jhaveri; Luis Beltran; Rajan Jain
Journal:  AJR Am J Roentgenol       Date:  2015-10-22       Impact factor: 3.959

10.  Voxel Level Radiologic-Pathologic Validation of Restriction Spectrum Imaging Cellularity Index with Gleason Grade in Prostate Cancer.

Authors:  Ghiam Yamin; Natalie M Schenker-Ahmed; Ahmed Shabaik; Dennis Adams; Hauke Bartsch; Joshua Kuperman; Nathan S White; Rebecca A Rakow-Penner; Kevin McCammack; J Kellogg Parsons; Christopher J Kane; Anders M Dale; David S Karow
Journal:  Clin Cancer Res       Date:  2016-06-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.